Zusammenfassung
Die aktinische Keratose (AK) ist definiert als Proliferation zytologisch atypischer Keratinozyten im Bereich der epidermodermalen Junktionszone in chronisch lichtgeschädigter Haut. Auf der nördlichen Hemisphäre liegt die Prävalenz von AK bei 11–25% der über 40-Jährigen. Die wesentliche Ursache für das Auftreten von AK ist die chronische Exposition gegenüber UVB-Licht (280–320 nm). Dadurch kommt es zu Mutationen des Telomerasegens und des Tumorsuppressorgens TP 53, das man in gleichem Maße auch bei invasiven spinozellulären Karzinomen (SSC) findet. Das Risiko der Ausbildung eines SSC aus AK innerhalb von 10 Jahren wird mit bis zu 16% angegeben. Histologisch lassen sich AK lediglich aufgrund der noch fehlenden Invasivität von SCC abgrenzen. Vor diesem Hintergrund und aufgrund der hohen Inzidenz der Erkrankung ist die begriffliche Neudefinition, beispielsweise als initiales spinozelluläres Karzinom, Gegenstand aktueller Diskussion. In der folgenden Übersicht werden aktuelle Aspekte zur Pathogenese und Therapie dargestellt.
Abstract
Actinic keratoses are defined as proliferation of cytologically atypical keratinocytes in the zone of epidermal-dermal junction in photodamaged skin. In the northern hemisphere the prevalence of actinic keratoses ranges depending on different epidemiological studies from 11% to 25% for people aged 40 or older. The main cause of actinic keratoses is exposure to UVB radiation in sunlight. UVB radiation induces mutations in the telomerase gene and in the tumor suppressor gene p53, which can also be detected in invasive squamous cell carcinoma. The only histological parameter to distinguish between actinic keratoses and SCC is the level of invasiveness. The risk for actinic keratoses to develop into SCC is about 16% over 10 years. For this reason and because of the high prevalence of actinic keratoses, it has been suggested to replace the term "actinic keratosis" with "intraepidermal squamous cell carcinoma" to better characterize the lesion. In the following review recent aspects of pathogenesis and therapy of actinic keratoses are discussed.
Literatur
Black HS (1998) Influence of dietary factors on actinically-induced skin cancer. Mutat Res 422:185–190
Brash DE, Ziegler A, Jonason AS et al. (1996) Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symp Proc 1:136–142
Campanelli A, Naldi L (2002) A retrospective study of the effect of long-term topical application of retinaldehyde (0.05%) on the development of actinic keratosis. Dermatology 205:146–152
Chen Z, Corey DR (2003) Telomerase inhibitors: a new option for chemotherapy. Adv Cancer Res 87:31–58
Dinehart SM, Nelson-Adesokan P, Cockerell C et al. (1997) Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer 79:920–923
Dinehart SM (2000) The treatment of actinic keratoses. J Am Acad Dermatol 42:25–28
Dodson JM, DeSpain J, Hewett JE, Clark DP (1991) Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol 127:1029–1031
Freudenthal W (1926) Verruca senilis und Keratoma senile. Arch Dermatol Syphilol (Berlin) 158:539–544
Frost CA, Green AC (1994) Epidemiology of solar keratoses. Br J Dermatol 131:455–464
Fu W, Cockerell CJ (2003) The actinic (solar) keratosis: a 21st-century perspective. Arch Dermatol 139:66–70
Fulton JE, Rahimi AD, Helton P, Dahlberg K, Kelly AG (1999) Disappointing results following resurfacing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers. Dermatol Surg 25:729–732
Gebauer K, Brown P, Varigos G (2003) Topical diclofenac in hyaluronan gel for the treatment of solar keratoses. Australas J Dermatol 44:40–43
Graham JH (1976) Precancerous lesions of the skin. Prim Care 2:699–716
Hurwitz RM, Monger LE (1995) Solar keratosis: an evolving squamous cell carcinoma. Benign or malignant? Dermatol Surg 21:184
Jiang SB, Levine VJ, Nehal KS et al. (2000) Er:YAG laser for the treatment of actinic keratoses. Dermatol Surg 26:437–440
Karagas MR, Greenberg ER, Spencer SK et al. (1999) Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 81:555–559
Kurwa HA, Yong-Gee SA, Seed PT et al. (1999) A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 41:414–418
Leffell DJ (2000) The scientific basis of skin cancer. J Am Acad Dermatol 42:18–22
Loven K, Stein L, Furst K, Levy S (2002) Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther 24:990–1000
Lubritz RR, Smolewski SA (1982) Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol 7:631–632
Marks R, Rennie G, Selwood TS (1988) Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1:795–797
Memon AA, Tomenson JA, Bothwell J, Friedmann PS (2000) Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 142:1154–1159
Meyer T, Arndt R, Christophers E, Nindl I, Stockfleth E (2001) Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev 25:533–547
Persaud AN, Shamuelova E, Sherer D et al. (2002) Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis. J Am Acad Dermatol 47:553–556
Pinkus H (1958) Keratosis senilis: a biologic concept of its pathogenesis and diagnosis based on the study of normal epidermis and 1730 seborrheic and senile keratoses. Am J Clin Pathol 29:193–207
Rosen RH, Studniberg H (2003) Solar keratoses: analysis in a dermatological practice in Australia. Australas J Dermatol 44:34–39
Sander CA, Pfeiffer C, Kligman AM, Plewig G (1997) Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin. J Am Acad Dermatol 36:236–238
Schwartz RA (1996) Therapeutic perspectives in actinic and other keratoses. Int J Dermatol 35:533–538
Stockfleth E, Meyer T, Benninghoff B et al. (2002) A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 138:1498–1502
Szeimies RM, Karrer S, Radakovic-Fijan S et al. (2002) Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 47:258–262
Thompson SC, Jolley D, Marks R (1993) Reduction of solar keratoses by regular sunscreen use. N Engl J Med 329:1147–1151
Ziegler A, Jonason AS, Leffell DJ et al. (1994) Sunburn and p53 in the onset of skin cancer. Nature 372:773–776
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Babilas, P., Landthaler, M. & Szeimies, RM. Die aktinische Keratose. Hautarzt 54, 551–562 (2003). https://doi.org/10.1007/s00105-003-0543-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-003-0543-0
Schlüsselwörter
- Initiales spinozelluläres Karzinom
- Invasives spinozelluläres Karzinom
- Sonnenschaden
- p53-Mutation
- Telomerasemutation
- Sonnenschutz